Sergio Duron
Amministratore Delegato presso Enlaza Therapeutics, Inc.
Patrimonio netto: 5 M $ in data 30/04/2024
Provenienza dei contatti di primo grado di Sergio Duron
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
University of Illinois
466
| College/University | Other Consumer Services | 466 |
The University of Texas at Austin
443
| College/University | Other Consumer Services | 443 |
Avalon Ventures Management LLC
 Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California.
7
| Private Company | Investment Managers | 7 |
Sova Pharmaceuticals, Inc.
 Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Enlaza Therapeutics, Inc.
 Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and is building a pipeline of first-in-class covalent biologics. The CEO of the company is Sergio G. Duron.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Nerio Therapeutics, Inc.
 Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sergio Duron tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| LOCKHEED MARTIN CORPORATION | Aerospace & Defense | Corporate Officer/Principal Corporate Officer/Principal | |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Biotechnology | Founder Corporate Officer/Principal | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
| ANAPTYSBIO, INC. | Biotechnology | Founder Chairman Director/Board Member | |
Afraxis, Inc.
 Afraxis, Inc. BiotechnologyHealth Technology Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA. | Biotechnology | Chief Executive Officer Director/Board Member Chief Operating Officer | |
Pictela, Inc.
 Pictela, Inc. Internet Software/ServicesTechnology Services Pictela is a global platform for distributing definition brand content. The platform reaches over 120 million consumers worldwide and supports 1 billion impressions per day. With Pictela, brands can deliver high definition video, photos, text and more. Since launching in 2009 with Disney and American Idol, Pictela has experienced rapid growth with clients across retail, CPG, automotive and entertainment categories. Pictela technology has been certified by Time Inc., The Wall Street Journal, Scripps Networks, Glam Media, Hearst, Rodale, Undertone and Thomson Reuters, among others. Pictela is based in the Flatiron District of New York City, the heart of the New York tech sector. The company is led by senior media and technology executives and backed by prominent venture capital investors. | Internet Software/Services | Director/Board Member Director/Board Member | |
Backupify, Inc.
 Backupify, Inc. Internet Software/ServicesTechnology Services Backupify, Inc. provides online backup solutions. Its products include google apps backup, office 365 backup, salesforce and social media backup, pricing and cloud to cloud backup. The company was founded by Vikram Chadha, Robert May and Dharmesh Shah in November 2008 and is headquartered in Boston, MA. | Internet Software/Services | Director/Board Member Director/Board Member | |
RQx Pharmaceuticals, Inc.
 RQx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RQx Pharmaceuticals, Inc. operates as a biopharmaceutical company developing small molecule antibiotics. The firm develops small molecule antibiotics to combat serious life threatening infections, including those caused by multi drug-resistant Gram-negative bacteria. It is developing novel, first-in-class antibiotics that evade the current abundance of antibiotic resistance mechanisms, which are now common across the globe. The company was founded in 2010 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
Redbooth, Inc.
 Redbooth, Inc. Internet Software/ServicesTechnology Services Redbooth, Inc. provides platform to share tasks, discussions, files, group chat and high definition video conferencing. It provides Teambox, a work management solution for freelancers, self-employed, small business owners, and large teams that allows individuals within and outside of an organization to work together in a social setting. The company was founded by Pablo Villalba Villar in 2008 and is headquartered in Palo Alto, CA. | Internet Software/Services | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Corporate Officer/Principal | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Analyst-Equity Corporate Officer/Principal | |
| Illinois Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree | |
Xenopharm, Inc.
 Xenopharm, Inc. Miscellaneous Commercial ServicesCommercial Services Xenopharm, Inc. develops drug sensing molecules. The company was founded by Ronald M. Evans and is headquartered in Sam Mateo, CA. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| The University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
| AKESIS PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Biomedical Acoustics Research Co.
 Biomedical Acoustics Research Co. Medical SpecialtiesHealth Technology Biomedical Acoustics Research Co. develops acoustic technologies for medical diagnoses. The firm focuses on gastrointestinal diseases, including intestinal obstruction, delayed gastric emptying, and gastrointestinal perforation. The company was founded in 1990 and is located in Evanston, IL. | Medical Specialties | Chief Tech/Sci/R&D Officer General Counsel | |
| Seoul National University | College/University | Undergraduate Degree Undergraduate Degree | |
Sytera, Inc.
 Sytera, Inc. BiotechnologyHealth Technology Part of Bausch Health Cos., Inc., Sytera, Inc. is a biopharmaceutical company that provides biopharmaceutical services and products. The company is based in La Jolla, CA. The company was founded by Jay B. Lichter, Kenneth J. Widder, Nathan L. Mata. Sytera was acquired by Sirion Therapeutics, Inc. on August 16, 2006 for $250 million. | Biotechnology | Director/Board Member Founder | |
Illinois Ventures LLC
 Illinois Ventures LLC Investment ManagersFinance Illinois Ventures LLC (Illinois Ventures) is a venture capital firm founded in 2000. The firm is headquartered in Champaign, Illinois. | Investment Managers | Corporate Officer/Principal Director/Board Member | |
The Northern Trust Co.
 The Northern Trust Co. Regional BanksFinance The Northern Trust Co. provides investment management, asset, fund administration, fiduciary and banking solutions. The company is headquartered in Chicago, IL. | Regional Banks | Corporate Officer/Principal Corporate Officer/Principal | |
| Avalon Ventures LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| OTONOMY | Biotechnology | Chief Executive Officer Chief Operating Officer | |
Carolus Therapeutics, Inc.
 Carolus Therapeutics, Inc. BiotechnologyHealth Technology Carolus Therapeutics, Inc. develops novel products for the treatment of inflammatory diseases. It company focuses on therapeutic strategies to noninvasively monitor and disrupt proinflammatory interactions of chemokines, and prevent or reverse inflammation associated with an array of human diseases, including atherosclerosis, rheumatoid arthritis, multiple sclerosis, sepsis, organ transplantation, and cancer. The company was founded by Jay Lichter, Jürgen Bernhagen, and Christian Weber in 2007 and is headquartered in San Diego, CA. | Biotechnology | Founder Director/Board Member Chief Executive Officer | |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
Getabl, Inc.
 Getabl, Inc. Internet Software/ServicesTechnology Services Getabl, Inc. provides consumer-to-business texting services. It is a service that replaces the phone conversation with a universal chat utility that allows consumers to send text messages to businesses and the business to reply by text message in real-time. The company was founded by Milenko Beslic, Bryan Lennett and Mark Slater in May 2010 and is headquartered in Boston, MA. | Internet Software/Services | Director/Board Member Director/Board Member | |
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
COI Pharmaceuticals, Inc.
 COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology COI Pharmaceuticals, Inc. provides life science investors. It offers research and development infrastructure and industry mentors to the portfolio companies of Avalon Ventures. The company was founded in 2013 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| SYNTHORX, INC. | Biotechnology | Chief Executive Officer Founder Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Talla, Inc.
 Talla, Inc. Packaged SoftwareTechnology Services Talla, Inc. provides artificial intelligence powered service desk to human resources, information technology and other internal service teams. The company was founded by Rob May in 2015 and is headquartered in Cambridge, MA. | Packaged Software | Director/Board Member Director/Board Member | |
Joy Life, Inc.
 Joy Life, Inc. Internet Software/ServicesTechnology Services Joy Life, Inc. provides wedding website and application. Its website and applications enable users to add photos, choose wedding colours and fonts, invite guests, send and store RSVP information and send messages. The company was founded by Michael Dorian Bach, Vishal Joshi and Kaiwalya Kher in 2014 and is headquartered in Seattle, WA. | Internet Software/Services | Director/Board Member Director/Board Member | |
Cellular Approaches, Inc.
 Cellular Approaches, Inc. BiotechnologyHealth Technology Cellular Approaches, Inc. operates in the biotechnology industry. It develops pipeline of innate immunity cell-based therapeutics for the treatment of infectious disease, autoimmunity, neurodegeneration and aging. The company was founded in 2016 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
ImmunOs Therapeutics AG
 ImmunOs Therapeutics AG BiotechnologyHealth Technology ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith. | Biotechnology | Director/Board Member Director/Board Member | |
| PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Chairman Director of Finance/CFO Director/Board Member | |
213 Management LLC
 213 Management LLC Investment ManagersFinance 213 Management LLC (213 Management) is a venture capital firm founded in 2003 by Bob Shapiro and Nick Rosa. The firm is headquartered in Chicago, Illinois. | Investment Managers | Corporate Officer/Principal Consultant / Advisor | |
Silarus Therapeutics, Inc.
 Silarus Therapeutics, Inc. BiotechnologyHealth Technology Silarus Therapeutics, Inc. develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. The company was founded by Tomas Ganz, Sanford J. Madigan, and Elizabeta Nemeth in May 19, 2014 and is headquartered in La Jolla, CA. | Biotechnology | Chief Executive Officer Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 49 |
| Corea del Sud | 2 |
| Svizzera | 2 |
Settori
| Health Technology | 20 |
| Consumer Services | 9 |
| Finance | 8 |
| Technology Services | 8 |
| Commercial Services | 5 |
Posizioni
| Director/Board Member | 346 |
| Corporate Officer/Principal | 183 |
| Undergraduate Degree | 92 |
| Graduate Degree | 69 |
| Private Equity Investor | 60 |
Contatti più connessi
| Insiders | |
|---|---|
| James Topper | 49 |
| Richard Levandov | 42 |
| Jay Lichter | 38 |
| Kevin Kinsella | 34 |
| Gary Pace | 32 |
| Shelley Chu | 31 |
| Daniel Crowley | 28 |
| Shawn T. Carolan | 24 |
| Sachin Gupta | 23 |
| Steven Sterin | 22 |
| Rob A. Newbold | 22 |
| Brady M. Bohrmann | 19 |
| Stephen L. Tomlin | 18 |
| Court Turner | 17 |
| Bradley Halverson | 17 |
- Borsa valori
- Insiders
- Sergio Duron
- Connessioni Società
